Previous close | 0.5500 |
Open | 0.5500 |
Bid | 0.0000 |
Ask | 0.9000 |
Strike | 22.00 |
Expiry date | 2022-06-17 |
Day's range | 0.5500 - 0.5500 |
Contract range | N/A |
Volume | |
Open interest | 1 |
CHICAGO, May 11, 2022--Researchers from Veradigm®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, diabetes, NASH (Non-Alcoholic Steatohepatitis), and cardiovascular disease at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Washington, D.C. from May 15-18, 2022.
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?